首页> 外文期刊>European thyroid journal >Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid Cancer?
【24h】

Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid Cancer?

机译:是否应在诊断中作为额外变量作为额外的变量包括分化的甲状腺癌患者的复发分类系统?

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To evaluate the influence of age at diagnosis on the frequency of structural incomplete response (SIR) according to the modified risk of recurrence (RR) staging system from the American Thyroid Association guidelines. Patients and Methods: We performed a retrospective analysis of 268 patients with differentiated thyroid cancer (DTC) followed up for at least 3 years after initial treatment (total thyroidectomy and remnant ablation). The median follow-up in the whole cohort was 74.3 months (range: 36.1-317.9) and the median age at diagnosis was 45.9 years (range: 18-87). The association between age at diagnosis and the initial and final response to treatment was assessed with analysis of variance (ANOVA). Patients were also divided into several groups considering age younger and older than 40,50, and 60 years. Results: Age at diagnosis was not associated with either an initial or final statistically significant different SIR to treatment (p = 0.14 and p = 0.58, respectively).
机译:目的:根据来自美国甲状腺协会协会指南的复发(RR)分期系统的修正风险,评估年龄对诊断频率的影响。 患者和方法:我们对初始治疗后至少3年(总甲状腺切除术和残留烧蚀)进行了268例分化甲状腺癌(DTC)进行了回顾性分析。 整个队列中的中位后续行动为74.3个月(范围:36.1-317.9),诊断的中位年龄为45.9岁(范围:18-87)。 通过差异分析评估诊断年龄和初始和最终反应的初始和最终反应的关联。 患者还分为几组,考虑年龄小于40,50,60岁。 结果:诊断年龄与初始或最终统计学上显着的不同SIR治疗无关(P = 0.14和P = 0.58)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号